Kimberly Kelly headshot
KK

Kimberly A. Kelly

Professor
Unit: School of Medicine
Department: Department of Biomedical Engineering
Office location and address
415 Lane Rd
Charlottesville, Virginia 22903
Education
BA, Hamilton College, Clinton NY
PhD, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
Biography

Kimberly A. Kelly, PhD is an Assistant Professor of Biomedical Engineering (BME) at the University of Virginia in Charlottesville, VA. Dr. Kelly received her Bachelor’s degree in Chemistry from Hamilton College in upstate NY, and her PhD from the University of Utah under the guidance of Dr. David Jones, PhD. Her thesis was using genomics and proteomics-based approaches to develop diagnostic reagents for colon cancer. After obtaining her PhD, Dr. Kelly took a postdoctoral fellowship position at the Center for Molecular Imaging Research at Massachusetts General Hospital (MGH), directed by Ralph Weissleder, under the guidance of Jennifer Allport Anderson. Under Dr. Allport Anderson’s guidance, Kim developed a VCAM-1 targeted imaging agent and was able to monitor VCAM-1 expression in mouse models of atherosclerosis. Further, she described a new interaction between VCAM-1 and SPARC that facilitates efficient leukocyte trafficking. In 2004, she was promoted to instructor of Radiology, and in 2008 to Assistant Professor of Radiology at MGH. In September of 2008, Dr. Kelly joined the Biomedical Engineering faculty at the University of Virginia as an Assistant Professor and was promoted to Associate Professor with tenure. Dr. Kelly is a member of SNM, the American Pancreatic Association, and the AACR. She was named a William Guy Forbeck Scholar in 2005 and awarded an AACR-Pancreatic Cancer Action Network Career Development award in 2007.

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
Source: U.S. NIH Cancer Institute
June 01, 2019 – May 31, 2024
MD-BIOM RWJF Health Policy Research Scholars Cohort Two - 2017 Samantha Perez
Source: Robert Wood Johnson Foundation
September 01, 2017 – August 31, 2022
AS-CHEM Towards GLIMPSE: Enabling Technology to map cytokines in inflamed tissue
Source: U.S. NIH Institute of Allergy & Infectious Disease
March 10, 2021 – February 28, 2022
MD-INMD AZ Master Agreement
Source: AstraZeneca
December 08, 2009 – December 31, 2021
Exploring CD38 molecular biology and imaging in multiple myeloma pathogenesis
Source: Washington University, The
June 01, 2020 – May 31, 2021
Taste Receptor Family 2 Member 9 as a novel target for imaging Cancer Associated Fibroblasts in pancreatic cancer
Source: U.S. NIH Cancer Institute
June 01, 2018 – May 31, 2020
MD-CVRC Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
Source: U.S. NIH Cancer Institute
September 08, 2014 – August 31, 2019
Signaling pathways attributed to plectin
Source: ITI Health, Inc.
September 01, 2017 – June 30, 2019
MD-BEIR Fluorescence Molecular Tomography to Study Tcell infiltration into tumors
Source: U.S. NIH Cancer Institute
August 01, 2014 – January 31, 2017
MD-CVRC In vivo phage display for the prevention of post infarct remodeling via targeted delivery of drugs to the infarct/border zone
Source: American Heart Association - Mid-Atlantic Affiliat
July 01, 2013 – June 30, 2015
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC
Source: U.S. NIH Cancer Institute
September 17, 2008 – July 31, 2014
Development of Molecularly Targeted Imaging Agents for KRAS activity in vivo
Source: U.S. NIH Institute of Biomedical Imaging & Bioengi
July 01, 2010 – March 31, 2014
BME 4550: Special Topics in Biomedical Engineering
Credits: 3
Applies engineering science, design methods, and system analysis to developing areas and current problems in biomedical engineering. Topics vary by semester. Recent topics include Medical Imaging Systems Theory, BME Advanced Design, BME Electronics Lab, and Systems Biology Modeling and Experimentation. Prerequisite: third- or fourth-year standing and instructor permission.
BME 4890: Nanomedicine
Credits: 3
Students will design treatment strategies for cancer and cardiovascular disease based on molecular bioengineering principles. Special topics will include design of nanoparticle drug and gene delivery platforms, materials biocompatibility, cancer immunotherapy, and molecular imaging. Prerequisite: BME 2104 or CHE 2246, BME 2220, fourth-year standing, or instructor permission; Recommended: BME 2240
BME 4995: Biomedical Engineering Advanced Projects
Credits: 1–3
A year-long research project in biomedical engineering conducted in consultation with a department faculty advisor; usually related to ongoing faculty research. Includes the design, execution, and analysis of experimental laboratory work and computational or theoretical computer analysis of a problem. Requires a comprehensive report of the results. Prerequisite: third- or fourth-year standing, and instructor permission.
BME 8995: M.E. Supervised Project Research (M.E. STUDENTS ONLY)
Credits: 1–6
FOR M.E. STUDENTS ONLY. A research project in biomedical engineering conducted in consultation with a faculty advisor. Includes the design, execution, and analysis of experimental laboratory work and computational or theoretical computer analysis of a problem. Fulfills the project requirement for the Biomedical Engineering Masters of Engineering degree. Prerequisites: Instructor Permission Required.
BME 8999: Master's Research
Credits: 1–12
Master's Research
BME 9999: Dissertation
Credits: 1–12
Formal record of student commitment to doctoral research under the guidance of a faculty advisor. May be repeated as necessary.
PHY 9999: Non-Topical Research
Credits: 1–12
For doctoral dissertation.
ZielBio, CEO & CSO http://itihealth.com/ https://zielbio.com/z-home